PULMONX CORPORATION (LUNG) Gross margin 2018–2025
PULMONX CORPORATION (LUNG) gross margin by fiscal year — reported gross profit divided by reported revenue.
74.2%FY2025 · since FY2018: 61.4% → 74.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 74.2% | +0.2 pp |
| FY2024 | 74.0% | +0.1 pp |
| FY2023 | 73.9% | -0.4 pp |
| FY2022 | 74.3% | +0.7 pp |
| FY2021 | 73.6% | +8.8 pp |
| FY2020 | 64.8% | -4.0 pp |
| FY2019 | 68.8% | +7.3 pp |
| FY2018 | 61.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LUNG financial trends
LUNG RevenueLUNG Net incomeLUNG Net marginLUNG Gross profitLUNG Operating incomeLUNG Operating marginLUNG Operating cash flowLUNG Free cash flowLUNG Capital expendituresLUNG Return on equityLUNG Stock buybacksLUNG Dividends paidLUNG Total assetsLUNG Total liabilitiesLUNG Shareholders’ equityLUNG overview →